Nature’s Sunshine Products (NASDAQ:NATR) PT Lowered to $21.00 at DA Davidson

Nature’s Sunshine Products (NASDAQ:NATR) had its price objective reduced by DA Davidson from $23.00 to $21.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the stock.

Nature’s Sunshine Products Stock Performance

Shares of NATR stock opened at $12.38 on Monday. Nature’s Sunshine Products has a 1-year low of $10.81 and a 1-year high of $21.72. The company has a current ratio of 2.33, a quick ratio of 1.42 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $231.88 million, a price-to-earnings ratio of 14.56 and a beta of 0.87. The stock’s fifty day simple moving average is $15.16 and its 200-day simple moving average is $17.04.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a net margin of 3.69% and a return on equity of 10.59%. The business had revenue of $110.55 million for the quarter.

Insider Activity at Nature’s Sunshine Products

In related news, EVP Bryant J. Yates sold 3,068 shares of Nature’s Sunshine Products stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $15.30, for a total transaction of $46,940.40. Following the completion of the sale, the executive vice president now owns 98,852 shares of the company’s stock, valued at $1,512,435.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 4.70% of the company’s stock.

Institutional Trading of Nature’s Sunshine Products

A number of institutional investors have recently bought and sold shares of NATR. Wasatch Advisors LP acquired a new stake in Nature’s Sunshine Products during the fourth quarter valued at $7,430,000. Skylands Capital LLC lifted its position in shares of Nature’s Sunshine Products by 722.1% in the second quarter. Skylands Capital LLC now owns 333,101 shares of the company’s stock worth $5,020,000 after buying an additional 292,581 shares during the last quarter. Paradigm Capital Management Inc. NY lifted its position in shares of Nature’s Sunshine Products by 26.8% in the second quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock worth $10,475,000 after buying an additional 146,879 shares during the last quarter. Hillsdale Investment Management Inc. lifted its position in shares of Nature’s Sunshine Products by 50.3% in the fourth quarter. Hillsdale Investment Management Inc. now owns 198,730 shares of the company’s stock worth $3,436,000 after buying an additional 66,500 shares during the last quarter. Finally, American Century Companies Inc. lifted its position in shares of Nature’s Sunshine Products by 25.7% in the second quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock worth $3,925,000 after buying an additional 53,221 shares during the last quarter. Institutional investors and hedge funds own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.